Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 586 AL 600

A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST)

Eyob E, Shaw JS, Bakker A, Munro C, Spira A, Wu M, Rabinowitz JA, Peters M, Wanigatunga S, Zipunnikov V, Thompson R, Burhanullah MH, Leoutsakos JM, Rosenberg P, Greenberg B.

J Alzheimers Dis. 2024;101(s1):S205-S215. doi: 10.3233/JAD-230635.

Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome

Meijer L, Chrétien E, Ravel D.

J Alzheimers Dis. 2024;101(s1):S95-S113. doi: 10.3233/JAD-240078.

The role of exercise in the prevention and treatment of Alzheimer's disease and mild cognitive impairments

Brooks CD, Krishnamoorthy RR, Sumien N.

Ageing Res Rev. 2024 Dec;102:102555. doi: 10.1016/j.arr.2024.102555. Epub 2024 Oct 28.

Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment

Lim AWY, Schneider L, Loy C.

Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.

Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress Disorder

Jain R, Chepke C, Davis LL, McIntyre RS, Raskind MA.

J Clin Psychiatry. 2024 Nov 8;85(4):plunaro2417ah. doi: 10.4088/JCP.plunaro2417ah.

Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial

Behl S, Slomkowski M, Chen D, Chang D, Hefting N, Lee D, Shah A, Estilo A, Kalu U, Hobart M.

J Alzheimers Dis. 2024 Nov;102(2):520-529. doi: 10.3233/JAD-240491. Epub 2024 Nov 13.

Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center

Shields LBE, Hust H, Cooley SD, Cooper GE, Hart RN, Dennis BC, Freeman SW, Cain JF, Shang WY, Wasz KM, Orr AT, Shields CB, Barve SS, Pugh KG.

J Prev Alzheimers Dis. 2024;11(6):1549-1562. doi: 10.14283/jpad.2024.159.

Effect of Social Isolation Due to the COVID-19 Pandemic on Cognitive Dysfunction of Patients With Alzheimer Disease: Subanalysis of Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets

Nakamura Y, Omori T, Nishiyama K, Ishikawa I, Aoki H, Nagakura N.

Alzheimer Dis Assoc Disord. 2024 Oct-Dec 01;38(4):351-357. doi: 10.1097/WAD.0000000000000648. Epub 2024 Nov 13.

Real-world diagnostic, referral, and treatment patterns in early Alzheimer's disease among community-based practices in the United States

Juday TR, Holub A, Mattke S, Betts KA, Kitchen SA, Liu H, Batrla R, Frech FH, Khachaturian AS.

J Alzheimers Dis. 2024 Dec;102(4):1172-1182. doi: 10.1177/13872877241297128. Epub 2024 Nov 29.

Use of Virtual Reality to Improve Spatial Orientation in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review

Gulin W, Oziemblewska M, Zajac-Lamparska L.

Curr Alzheimer Res. 2024;21(11):804-816. doi: 10.2174/0115672050374807250224044204.

Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial

Brum WS, Docherty KF, Ashton NJ, Zetterberg H, Hansson O, McMurray JJV, Blennow K.

JAMA Neurol. 2024 Feb 1;81(2):197-200. doi: 10.1001/jamaneurol.2023.4719.

Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease

Weinberg MS, He Y, Kivisäkk P, Arnold SE, Das S.

J Alzheimers Dis. 2024;99(s2):S355-S365. doi: 10.3233/JAD-230899.

Navigating the dementia landscape: Biomarkers and emerging therapies

Maheshwari S, Singh A, Ansari VA, Mahmood T, Wasim R, Akhtar J, Verma A.

Ageing Res Rev. 2024 Feb;94:102193. doi: 10.1016/j.arr.2024.102193. Epub 2024 Jan 10.

A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease

van Dyck CH, Mecca AP, O'Dell RS, Bartlett HH, Diepenbrock NG, Huang Y, Hamby ME, Grundman M, Catalano SM, Caggiano AO, Carson RE.

Alzheimers Res Ther. 2024 Jan 25;16(1):20. doi: 10.1186/s13195-024-01382-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias